Diosmin 95 Complex. Product License. Stragen Pharma. April 1, 2011.
Chauvenet M, Libeskind M. Intérêt de la diosmine d'hèmisynthèse dans la poussée hémorroïdaire aiguë (Interest of semisynthetic diosmin in acute hemorrhoidal pressure). Revue française de gastro-entérologie 1994;303 :642-7. Multicentre, double-blind study of 94 patients suffering from either external hemorrhoidal thrombosis requiring medical treatment or internal congestive hemorrhoidal crisis who were randomized to diosmin 600mg (3 tablets TID for 4 days and 2 tablets/day for 3 days) or placebo.
Debien P, Denis J. Traitement des signes fonctionnels de la crise hémorroïdaire aiguë (Treatment of functional symptoms of acute hemorrhoidal attack). Actualités Therapéutiques 1996;25(5):259-64. Multicentre, double-blind study of 127 patients suffering from hemorrhoidal crisis with pain evolving for at least 48 hrs, who were randomized to diosmin (DH) 600 mg (3 tablets/day for 7 days) or Ginkgo biloba extract-heptamitol-troxerutin (GHT) (4 tablets/day for 7 days).
Metrika. Hemorrhoid Market U&A and NPOT Study: Report of Findings. November, 2013. Online market research survey conducted between October 7 and 17, 2013 among 1000 hemorrhoid sufferers across Canada who had bought an OTC hemorrhoid treatment in the past 6 months.
